Advertisement

Index by Author

July 1997; 46 (7)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abrams-Carter, L

    • PPAR-gamma gene expression is elevated in skeletal muscle of obese and type II diabetic subjects. Diabetes July 1997 46:1230-1234; doi:10.2337/diabetes.46.7.1230

  2. Alcázar, O

    • Stimulation of islet protein kinase C translocation by palmitate requires metabolism of the fatty acid. Diabetes July 1997 46:1153-1158; doi:10.2337/diabetes.46.7.1153

  3. Alejandro, R

    • Improved human islet isolation using a new enzyme blend, liberase. Diabetes July 1997 46:1120-1123; doi:10.2337/diabetes.46.7.1120

  4. Altieri, M

    • Inhibition of diabetes by an insulin-reactive CD4 T-cell clone in the nonobese diabetic mouse. Diabetes July 1997 46:1124-1132; doi:10.2337/diabetes.46.7.1124

  5. Anello, M

    • Hexokinase shift to mitochondria is associated with an increased sensitivity to glucose in rat pancreatic islets. Diabetes July 1997 46:1148-1152; doi:10.2337/diabetes.46.7.1148

  6. Ayad, M F

    • Differences between the tolbutamide-boosted and the insulin-modified minimal model protocols. Diabetes July 1997 46:1167-1171; doi:10.2337/diabetes.46.7.1167

B

  1. Bell, G I

    • The 31-cM region of chromosome 11 including the obesity gene tubby and ATP-sensitive potassium channel genes, SUR1 and Kir6.2, does not contain a major susceptibility locus for NIDDM in 127 non-Hispanic white affected sibships. Diabetes July 1997 46:1227-1229

  2. Bergman, R N

    • Differences between the tolbutamide-boosted and the insulin-modified minimal model protocols. Diabetes July 1997 46:1167-1171; doi:10.2337/diabetes.46.7.1167

  3. Bolli, G B

    • Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation. Diabetes July 1997 46:1172-1181; doi:10.2337/diabetes.46.7.1172

  4. Bornstein, S R

    • Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland: leptin inhibits cortisol release directly. Diabetes July 1997 46:1235-1238; doi:10.2337/diabetes.46.7.1235

  5. Bottini, P

    • Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation. Diabetes July 1997 46:1172-1181; doi:10.2337/diabetes.46.7.1172

  6. Bottino, R

    • Improved human islet isolation using a new enzyme blend, liberase. Diabetes July 1997 46:1120-1123; doi:10.2337/diabetes.46.7.1120

  7. Boyadjian, R

    • Differences between the tolbutamide-boosted and the insulin-modified minimal model protocols. Diabetes July 1997 46:1167-1171; doi:10.2337/diabetes.46.7.1167

  8. Brunetti, P

    • Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation. Diabetes July 1997 46:1172-1181; doi:10.2337/diabetes.46.7.1172

C

  1. Caixàs, A

    • Optimization of glycemic control by insulin therapy decreases the proportion of small dense LDL particles in diabetic patients. Diabetes July 1997 46:1207-1213; doi:10.2337/diabetes.46.7.1207

  2. Caltabiano, V

    • Early, but not advanced, glomerulopathy is reversed by pancreatic islet transplants in experimental diabetic rats: correlation with glomerular extracellular matrix mRNA levels. Diabetes July 1997 46:1198-1206; doi:10.2337/diabetes.46.7.1198

  3. Ciaraldi, T P

    • PPAR-gamma gene expression is elevated in skeletal muscle of obese and type II diabetic subjects. Diabetes July 1997 46:1230-1234; doi:10.2337/diabetes.46.7.1230

  4. Ciofetta, M

    • Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation. Diabetes July 1997 46:1172-1181; doi:10.2337/diabetes.46.7.1172

  5. Cox, N J

    • The 31-cM region of chromosome 11 including the obesity gene tubby and ATP-sensitive potassium channel genes, SUR1 and Kir6.2, does not contain a major susceptibility locus for NIDDM in 127 non-Hispanic white affected sibships. Diabetes July 1997 46:1227-1229

D

  1. De Hertogh, R

    • Increased synthesis of tumor necrosis factor-alpha in uterine explants from pregnant diabetic rats and in primary cultures of uterine cells in high glucose. Diabetes July 1997 46:1214-1224; doi:10.2337/diabetes.46.7.1214

  2. de Leiva, A

    • Optimization of glycemic control by insulin therapy decreases the proportion of small dense LDL particles in diabetic patients. Diabetes July 1997 46:1207-1213; doi:10.2337/diabetes.46.7.1207

  3. Del Sindaco, P

    • Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation. Diabetes July 1997 46:1172-1181; doi:10.2337/diabetes.46.7.1172

  4. Demenais, F

    • Mapping NIDDM susceptibility loci in French families: studies with markers in the region of NIDDM1 on chromosome 2q. Diabetes July 1997 46:1225-1226

  5. Di Mario, U

    • Early, but not advanced, glomerulopathy is reversed by pancreatic islet transplants in experimental diabetic rats: correlation with glomerular extracellular matrix mRNA levels. Diabetes July 1997 46:1198-1206; doi:10.2337/diabetes.46.7.1198

  6. Di Vincenzo, A

    • Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation. Diabetes July 1997 46:1172-1181; doi:10.2337/diabetes.46.7.1172

E

  1. Ehrhart-Bornstein, M

    • Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland: leptin inhibits cortisol release directly. Diabetes July 1997 46:1235-1238; doi:10.2337/diabetes.46.7.1235

  2. Elsewafy, W A

    • Differences between the tolbutamide-boosted and the insulin-modified minimal model protocols. Diabetes July 1997 46:1167-1171; doi:10.2337/diabetes.46.7.1167

F

  1. Fanelli, C

    • Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation. Diabetes July 1997 46:1172-1181; doi:10.2337/diabetes.46.7.1172

  2. Froguel, P

    • Mapping NIDDM susceptibility loci in French families: studies with markers in the region of NIDDM1 on chromosome 2q. Diabetes July 1997 46:1225-1226

G

  1. Gall, M A

    • Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. Diabetes July 1997 46:1182-1188; doi:10.2337/diabetes.46.7.1182

  2. Giacca, A

    • Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans. Diabetes July 1997 46:1111-1119; doi:10.2337/diabetes.46.7.1111

  3. Giné, E

    • Stimulation of islet protein kinase C translocation by palmitate requires metabolism of the fatty acid. Diabetes July 1997 46:1153-1158; doi:10.2337/diabetes.46.7.1153

  4. Gragnoli, C

    • The 31-cM region of chromosome 11 including the obesity gene tubby and ATP-sensitive potassium channel genes, SUR1 and Kir6.2, does not contain a major susceptibility locus for NIDDM in 127 non-Hispanic white affected sibships. Diabetes July 1997 46:1227-1229

  5. Greiner, D L

    • Dietary cow's milk protein does not alter the frequency of diabetes in the BB rat. Diabetes July 1997 46:1133-1140; doi:10.2337/diabetes.46.7.1133

  6. Gurlo, T

    • Inhibition of diabetes by an insulin-reactive CD4 T-cell clone in the nonobese diabetic mouse. Diabetes July 1997 46:1124-1132; doi:10.2337/diabetes.46.7.1124

H

  1. Hager, J

    • Mapping NIDDM susceptibility loci in French families: studies with markers in the region of NIDDM1 on chromosome 2q. Diabetes July 1997 46:1225-1226

  2. Haidan, A

    • Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland: leptin inhibits cortisol release directly. Diabetes July 1997 46:1235-1238; doi:10.2337/diabetes.46.7.1235

  3. Hämäläinen, S

    • Incorporation of [3-3H]glucose and 2-[1-14C]deoxyglucose into glycogen in heart and skeletal muscle in vivo: implications for the quantitation of tissue glucose uptake. Diabetes July 1997 46:1106-1110; doi:10.2337/diabetes.46.7.1106

  4. Hani, E H

    • Mapping NIDDM susceptibility loci in French families: studies with markers in the region of NIDDM1 on chromosome 2q. Diabetes July 1997 46:1225-1226

  5. Hansen, J W

    • Dietary cow's milk protein does not alter the frequency of diabetes in the BB rat. Diabetes July 1997 46:1133-1140; doi:10.2337/diabetes.46.7.1133

  6. Harley, P

    • Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans. Diabetes July 1997 46:1111-1119; doi:10.2337/diabetes.46.7.1111

  7. Harris, R B

    • Voluntary wheel running decreases adipose tissue mass and expression of leptin mRNA in Osborne-Mendel rats. Diabetes July 1997 46:1159-1166; doi:10.2337/diabetes.46.7.1159

  8. Hendry, S L

    • Voluntary wheel running decreases adipose tissue mass and expression of leptin mRNA in Osborne-Mendel rats. Diabetes July 1997 46:1159-1166; doi:10.2337/diabetes.46.7.1159

  9. Henry, R R

    • PPAR-gamma gene expression is elevated in skeletal muscle of obese and type II diabetic subjects. Diabetes July 1997 46:1230-1234; doi:10.2337/diabetes.46.7.1230

  10. Homs, R

    • Optimization of glycemic control by insulin therapy decreases the proportion of small dense LDL particles in diabetic patients. Diabetes July 1997 46:1207-1213; doi:10.2337/diabetes.46.7.1207

I

  1. Inverardi, L

    • Improved human islet isolation using a new enzyme blend, liberase. Diabetes July 1997 46:1120-1123; doi:10.2337/diabetes.46.7.1120

  2. Ito, M

    • Neural tube defects in embryos of diabetic mice: role of the Pax-3 gene and apoptosis. Diabetes July 1997 46:1189-1197; doi:10.2337/diabetes.46.7.1189

J

  1. Jinagouda, S D

    • Differences between the tolbutamide-boosted and the insulin-modified minimal model protocols. Diabetes July 1997 46:1167-1171; doi:10.2337/diabetes.46.7.1167

K

  1. Kades, W W

    • Differences between the tolbutamide-boosted and the insulin-modified minimal model protocols. Diabetes July 1997 46:1167-1171; doi:10.2337/diabetes.46.7.1167

  2. Kanda, T

    • Augmentation of hepatic glucose uptake by a positive glucose gradient between hepatoportal and central nervous systems. Diabetes July 1997 46:1101-1105; doi:10.2337/diabetes.46.7.1101

  3. Kawamori, R

    • Augmentation of hepatic glucose uptake by a positive glucose gradient between hepatoportal and central nervous systems. Diabetes July 1997 46:1101-1105; doi:10.2337/diabetes.46.7.1101

  4. Kubota, M

    • Augmentation of hepatic glucose uptake by a positive glucose gradient between hepatoportal and central nervous systems. Diabetes July 1997 46:1101-1105; doi:10.2337/diabetes.46.7.1101

L

  1. Lalli, C

    • Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation. Diabetes July 1997 46:1172-1181; doi:10.2337/diabetes.46.7.1172

  2. Lehmann, R

    • Improved human islet isolation using a new enzyme blend, liberase. Diabetes July 1997 46:1120-1123; doi:10.2337/diabetes.46.7.1120

  3. Lenti, E

    • Early, but not advanced, glomerulopathy is reversed by pancreatic islet transplants in experimental diabetic rats: correlation with glomerular extracellular matrix mRNA levels. Diabetes July 1997 46:1198-1206; doi:10.2337/diabetes.46.7.1198

  4. Lepore, M

    • Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation. Diabetes July 1997 46:1172-1181; doi:10.2337/diabetes.46.7.1172

  5. Lewis, G F

    • Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans. Diabetes July 1997 46:1111-1119; doi:10.2337/diabetes.46.7.1111

  6. Lindner, T

    • The 31-cM region of chromosome 11 including the obesity gene tubby and ATP-sensitive potassium channel genes, SUR1 and Kir6.2, does not contain a major susceptibility locus for NIDDM in 127 non-Hispanic white affected sibships. Diabetes July 1997 46:1227-1229

  7. Linetsky, E

    • Improved human islet isolation using a new enzyme blend, liberase. Diabetes July 1997 46:1120-1123; doi:10.2337/diabetes.46.7.1120

  8. Loeken, M R

    • Neural tube defects in embryos of diabetic mice: role of the Pax-3 gene and apoptosis. Diabetes July 1997 46:1189-1197; doi:10.2337/diabetes.46.7.1189

M

  1. Malkani, S

    • Dietary cow's milk protein does not alter the frequency of diabetes in the BB rat. Diabetes July 1997 46:1133-1140; doi:10.2337/diabetes.46.7.1133

  2. Matsuhisa, M

    • Augmentation of hepatic glucose uptake by a positive glucose gradient between hepatoportal and central nervous systems. Diabetes July 1997 46:1101-1105; doi:10.2337/diabetes.46.7.1101

  3. Mordes, J P

    • Dietary cow's milk protein does not alter the frequency of diabetes in the BB rat. Diabetes July 1997 46:1133-1140; doi:10.2337/diabetes.46.7.1133

  4. Morishima, T

    • Augmentation of hepatic glucose uptake by a positive glucose gradient between hepatoportal and central nervous systems. Diabetes July 1997 46:1101-1105; doi:10.2337/diabetes.46.7.1101

  5. Mudaliar, S

    • PPAR-gamma gene expression is elevated in skeletal muscle of obese and type II diabetic subjects. Diabetes July 1997 46:1230-1234; doi:10.2337/diabetes.46.7.1230

N

  1. Nakahara, I

    • Augmentation of hepatic glucose uptake by a positive glucose gradient between hepatoportal and central nervous systems. Diabetes July 1997 46:1101-1105; doi:10.2337/diabetes.46.7.1101

  2. Nielsen, F S

    • Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. Diabetes July 1997 46:1182-1188; doi:10.2337/diabetes.46.7.1182

  3. Nikoulina, S E

    • PPAR-gamma gene expression is elevated in skeletal muscle of obese and type II diabetic subjects. Diabetes July 1997 46:1230-1234; doi:10.2337/diabetes.46.7.1230

  4. Nompleggi, D

    • Dietary cow's milk protein does not alter the frequency of diabetes in the BB rat. Diabetes July 1997 46:1133-1140; doi:10.2337/diabetes.46.7.1133

O

  1. Ordóñez-Llanos, J

    • Optimization of glycemic control by insulin therapy decreases the proportion of small dense LDL particles in diabetic patients. Diabetes July 1997 46:1207-1213; doi:10.2337/diabetes.46.7.1207

P

  1. Pampanelli, S

    • Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation. Diabetes July 1997 46:1172-1181; doi:10.2337/diabetes.46.7.1172

  2. Pampfer, S

    • Increased synthesis of tumor necrosis factor-alpha in uterine explants from pregnant diabetic rats and in primary cultures of uterine cells in high glucose. Diabetes July 1997 46:1214-1224; doi:10.2337/diabetes.46.7.1214

  3. Park, K S

    • PPAR-gamma gene expression is elevated in skeletal muscle of obese and type II diabetic subjects. Diabetes July 1997 46:1230-1234; doi:10.2337/diabetes.46.7.1230

  4. Parving, H H

    • Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. Diabetes July 1997 46:1182-1188; doi:10.2337/diabetes.46.7.1182

  5. Patanè, G

    • Hexokinase shift to mitochondria is associated with an increased sensitivity to glucose in rat pancreatic islets. Diabetes July 1997 46:1148-1152; doi:10.2337/diabetes.46.7.1148

  6. Payés, A

    • Optimization of glycemic control by insulin therapy decreases the proportion of small dense LDL particles in diabetic patients. Diabetes July 1997 46:1207-1213; doi:10.2337/diabetes.46.7.1207

  7. Pérez, A

    • Optimization of glycemic control by insulin therapy decreases the proportion of small dense LDL particles in diabetic patients. Diabetes July 1997 46:1207-1213; doi:10.2337/diabetes.46.7.1207

  8. Pesce, C

    • Early, but not advanced, glomerulopathy is reversed by pancreatic islet transplants in experimental diabetic rats: correlation with glomerular extracellular matrix mRNA levels. Diabetes July 1997 46:1198-1206; doi:10.2337/diabetes.46.7.1198

  9. Petzold, C

    • The 31-cM region of chromosome 11 including the obesity gene tubby and ATP-sensitive potassium channel genes, SUR1 and Kir6.2, does not contain a major susceptibility locus for NIDDM in 127 non-Hispanic white affected sibships. Diabetes July 1997 46:1227-1229

  10. Phelan, S A

    • Neural tube defects in embryos of diabetic mice: role of the Pax-3 gene and apoptosis. Diabetes July 1997 46:1189-1197; doi:10.2337/diabetes.46.7.1189

  11. Philippi, A

    • Mapping NIDDM susceptibility loci in French families: studies with markers in the region of NIDDM1 on chromosome 2q. Diabetes July 1997 46:1225-1226

  12. Piro, S

    • Hexokinase shift to mitochondria is associated with an increased sensitivity to glucose in rat pancreatic islets. Diabetes July 1997 46:1148-1152; doi:10.2337/diabetes.46.7.1148

  13. Porcellati, F

    • Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation. Diabetes July 1997 46:1172-1181; doi:10.2337/diabetes.46.7.1172

  14. Pricci, F

    • Early, but not advanced, glomerulopathy is reversed by pancreatic islet transplants in experimental diabetic rats: correlation with glomerular extracellular matrix mRNA levels. Diabetes July 1997 46:1198-1206; doi:10.2337/diabetes.46.7.1198

  15. Pugliese, G

    • Early, but not advanced, glomerulopathy is reversed by pancreatic islet transplants in experimental diabetic rats: correlation with glomerular extracellular matrix mRNA levels. Diabetes July 1997 46:1198-1206; doi:10.2337/diabetes.46.7.1198

  16. Purrello, F

    • Hexokinase shift to mitochondria is associated with an increased sensitivity to glucose in rat pancreatic islets. Diabetes July 1997 46:1148-1152; doi:10.2337/diabetes.46.7.1148
    • Early, but not advanced, glomerulopathy is reversed by pancreatic islet transplants in experimental diabetic rats: correlation with glomerular extracellular matrix mRNA levels. Diabetes July 1997 46:1198-1206; doi:10.2337/diabetes.46.7.1198

Q

  1. Qiu-yue, Z

    • Stimulation of islet protein kinase C translocation by palmitate requires metabolism of the fatty acid. Diabetes July 1997 46:1153-1158; doi:10.2337/diabetes.46.7.1153

R

  1. Rabuazzo, A M

    • Hexokinase shift to mitochondria is associated with an increased sensitivity to glucose in rat pancreatic islets. Diabetes July 1997 46:1148-1152; doi:10.2337/diabetes.46.7.1148

  2. Ricordi, C

    • Improved human islet isolation using a new enzyme blend, liberase. Diabetes July 1997 46:1120-1123; doi:10.2337/diabetes.46.7.1120

  3. Rietzsch, H

    • The 31-cM region of chromosome 11 including the obesity gene tubby and ATP-sensitive potassium channel genes, SUR1 and Kir6.2, does not contain a major susceptibility locus for NIDDM in 127 non-Hispanic white affected sibships. Diabetes July 1997 46:1227-1229

  4. Rissanen, E

    • Incorporation of [3-3H]glucose and 2-[1-14C]deoxyglucose into glycogen in heart and skeletal muscle in vivo: implications for the quantitation of tissue glucose uptake. Diabetes July 1997 46:1106-1110; doi:10.2337/diabetes.46.7.1106

  5. Romeo, G

    • Early, but not advanced, glomerulopathy is reversed by pancreatic islet transplants in experimental diabetic rats: correlation with glomerular extracellular matrix mRNA levels. Diabetes July 1997 46:1198-1206; doi:10.2337/diabetes.46.7.1198

  6. Rossing, P

    • Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. Diabetes July 1997 46:1182-1188; doi:10.2337/diabetes.46.7.1182

  7. Rossini, A A

    • Dietary cow's milk protein does not alter the frequency of diabetes in the BB rat. Diabetes July 1997 46:1133-1140; doi:10.2337/diabetes.46.7.1133

S

  1. Saad, M F

    • Differences between the tolbutamide-boosted and the insulin-modified minimal model protocols. Diabetes July 1997 46:1167-1171; doi:10.2337/diabetes.46.7.1167

  2. Scherbaum, W A

    • Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland: leptin inhibits cortisol release directly. Diabetes July 1997 46:1235-1238; doi:10.2337/diabetes.46.7.1235

  3. Schröder, H E

    • The 31-cM region of chromosome 11 including the obesity gene tubby and ATP-sensitive potassium channel genes, SUR1 and Kir6.2, does not contain a major susceptibility locus for NIDDM in 127 non-Hispanic white affected sibships. Diabetes July 1997 46:1227-1229

  4. Schulze, J

    • The 31-cM region of chromosome 11 including the obesity gene tubby and ATP-sensitive potassium channel genes, SUR1 and Kir6.2, does not contain a major susceptibility locus for NIDDM in 127 non-Hispanic white affected sibships. Diabetes July 1997 46:1227-1229

  5. Sherwin, R S

    • Inhibition of diabetes by an insulin-reactive CD4 T-cell clone in the nonobese diabetic mouse. Diabetes July 1997 46:1124-1132; doi:10.2337/diabetes.46.7.1124

  6. Shiba, Y

    • Augmentation of hepatic glucose uptake by a positive glucose gradient between hepatoportal and central nervous systems. Diabetes July 1997 46:1101-1105; doi:10.2337/diabetes.46.7.1101

  7. Sjöholm, A

    • Glucose stimulates islet beta-cell mitogenesis through GTP-binding proteins and by protein kinase C-dependent mechanisms. Diabetes July 1997 46:1141-1147; doi:10.2337/diabetes.46.7.1141

  8. Skøtt, P

    • Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. Diabetes July 1997 46:1182-1188; doi:10.2337/diabetes.46.7.1182

  9. Smidt, U M

    • Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. Diabetes July 1997 46:1182-1188; doi:10.2337/diabetes.46.7.1182

  10. Smith, S R

    • Voluntary wheel running decreases adipose tissue mass and expression of leptin mRNA in Osborne-Mendel rats. Diabetes July 1997 46:1159-1166; doi:10.2337/diabetes.46.7.1159

  11. Steil, G M

    • Differences between the tolbutamide-boosted and the insulin-modified minimal model protocols. Diabetes July 1997 46:1167-1171; doi:10.2337/diabetes.46.7.1167

T

  1. Tamarit-Rodriguez, J

    • Stimulation of islet protein kinase C translocation by palmitate requires metabolism of the fatty acid. Diabetes July 1997 46:1153-1158; doi:10.2337/diabetes.46.7.1153

  2. Tomita, T

    • Augmentation of hepatic glucose uptake by a positive glucose gradient between hepatoportal and central nervous systems. Diabetes July 1997 46:1101-1105; doi:10.2337/diabetes.46.7.1101

U

  1. Uhlmann, K

    • Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland: leptin inhibits cortisol release directly. Diabetes July 1997 46:1235-1238; doi:10.2337/diabetes.46.7.1235

  2. Utriainen, T

    • Incorporation of [3-3H]glucose and 2-[1-14C]deoxyglucose into glycogen in heart and skeletal muscle in vivo: implications for the quantitation of tissue glucose uptake. Diabetes July 1997 46:1106-1110; doi:10.2337/diabetes.46.7.1106

V

  1. Vanderheyden, I

    • Increased synthesis of tumor necrosis factor-alpha in uterine explants from pregnant diabetic rats and in primary cultures of uterine cells in high glucose. Diabetes July 1997 46:1214-1224; doi:10.2337/diabetes.46.7.1214

  2. Vetri, M

    • Early, but not advanced, glomerulopathy is reversed by pancreatic islet transplants in experimental diabetic rats: correlation with glomerular extracellular matrix mRNA levels. Diabetes July 1997 46:1198-1206; doi:10.2337/diabetes.46.7.1198

  3. Vigneri, R

    • Hexokinase shift to mitochondria is associated with an increased sensitivity to glucose in rat pancreatic islets. Diabetes July 1997 46:1148-1152; doi:10.2337/diabetes.46.7.1148

  4. Vionnet, N

    • Mapping NIDDM susceptibility loci in French families: studies with markers in the region of NIDDM1 on chromosome 2q. Diabetes July 1997 46:1225-1226

  5. Virkamäki, A

    • Incorporation of [3-3H]glucose and 2-[1-14C]deoxyglucose into glycogen in heart and skeletal muscle in vivo: implications for the quantitation of tissue glucose uptake. Diabetes July 1997 46:1106-1110; doi:10.2337/diabetes.46.7.1106

  6. von Grafenstein, H

    • Inhibition of diabetes by an insulin-reactive CD4 T-cell clone in the nonobese diabetic mouse. Diabetes July 1997 46:1124-1132; doi:10.2337/diabetes.46.7.1124

  7. Vranic, M

    • Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans. Diabetes July 1997 46:1111-1119; doi:10.2337/diabetes.46.7.1111

W

  1. Wada, M

    • Augmentation of hepatic glucose uptake by a positive glucose gradient between hepatoportal and central nervous systems. Diabetes July 1997 46:1101-1105; doi:10.2337/diabetes.46.7.1101

  2. Wen, L

    • Inhibition of diabetes by an insulin-reactive CD4 T-cell clone in the nonobese diabetic mouse. Diabetes July 1997 46:1124-1132; doi:10.2337/diabetes.46.7.1124

  3. Wong, F S

    • Inhibition of diabetes by an insulin-reactive CD4 T-cell clone in the nonobese diabetic mouse. Diabetes July 1997 46:1124-1132; doi:10.2337/diabetes.46.7.1124

Y

  1. Yamasaki, Y

    • Augmentation of hepatic glucose uptake by a positive glucose gradient between hepatoportal and central nervous systems. Diabetes July 1997 46:1101-1105; doi:10.2337/diabetes.46.7.1101

  2. Yki-Järvinen, H

    • Incorporation of [3-3H]glucose and 2-[1-14C]deoxyglucose into glycogen in heart and skeletal muscle in vivo: implications for the quantitation of tissue glucose uptake. Diabetes July 1997 46:1106-1110; doi:10.2337/diabetes.46.7.1106

Z

  1. Zachwieja, J J

    • Voluntary wheel running decreases adipose tissue mass and expression of leptin mRNA in Osborne-Mendel rats. Diabetes July 1997 46:1159-1166; doi:10.2337/diabetes.46.7.1159

  2. Zekzer, D

    • Inhibition of diabetes by an insulin-reactive CD4 T-cell clone in the nonobese diabetic mouse. Diabetes July 1997 46:1124-1132; doi:10.2337/diabetes.46.7.1124

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement